Patent ID: 9005601
Filing Date: 2015-04-14
Classification: A23K,A23L,A61K,A61P,C12N

Abstract:
1. A probiotic formulation comprising a bacterial isolate selected from the group of Bacillus subtilis AM0904 (NRRL Deposit Number B-50914), Bacillus subtilis AM0911 (NRRL Deposit Number B-50915), Bacillus subtilis NP122 (NRRL Deposit Number B-50910), Bacillus subtilis NP119B (NRRL Deposit Number B-50909), B. licheniformis B1 (NRRL Deposit Number B-50907), B. subtilis B2 (Deposit Number B-50908), B. licheniformis RW25 (NRRL Deposit Number B-50911), B. licheniformis RW32 (NRRL Deposit Number B-50912), and B. licheniformis RW41 (NRRL Deposit Number B-50913), wherein the formulation comprises at least one Bacillus subtilis isolate and at least one Bacillus licheniformis isolate, or at least two Bacillus subtilis isolates.